Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.00%
)
US TECH 100
29,347.20
(
0.47%
)
Dow Jones
50,461.68
(
0.00%
)
Brent Oil
93.25
(
-3.85%
)
Bitcoin
74,798.64
(
-1.36%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: corpstrat post# 58979

Wednesday, 02/13/2008 7:06:33 PM

Wednesday, February 13, 2008 7:06:33 PM

Post# of 257644
ZGEN: I'm a proponent of shareholder value via clinical progress, as I'd imagine you are. However, I understand your comments as presented.
Interestingly, post-earnings/after-market it appears that someone misunderstood the 2008 rev guidance, which DID NOT include any RECOTHROM sales. Otherwise, the guidance is above forecast, imo.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today